Found 35 matching trials
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE VÂŽ Everolimus Eluting Coronary Stent System PHASE3 The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Show More Location
Scottsdale Healthcare
Learn More & Join Trial
SPIRIT III Clinical Trial of the XIENCE VÂŽ Everolimus Eluting Coronary Stent System (EECSS) PHASE3 This study is divided into 5 arms:
1. Randomized Clinical Trial (RCT): Pro...
Show More Location
Baptist Medical Center Princeton
Learn More & Join Trial
XIENCE VÂŽ Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study N/A XIENCE VÂŽ India is a prospective, open-label, multi-center, observational, ...
Show More Learn More & Join Trial
A Clinical Evaluation of Absorb⢠Bioresorbable Vascular Scaffold (Absorb⢠BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) NA To evaluate the safety and efficacy of the Absorb BVS System compared to th...
Show More Learn More & Join Trial
ABSORB PHYSIOLOGY Clinical Investigation NA The target enrollment goal for the trial was to enroll 36 subjects. However...
Show More Learn More & Join Trial
SPIRIT Small Vessel Registry NA To evaluate the safety and effectiveness of the 2.25 mm XIENCE VÂŽ Everolimu...
Show More Location
Scottsdale Healthcare
Learn More & Join Trial
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents N/A Prospective, multicenter, registry of at least 11,000 (and up to 15,000) co...
Show More Location
Minneapolis Heart Institute
Learn More & Join Trial
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques PHASE4 The purpose of this study is to evaluate the efficacy and safety of the tre...
Show More Location
Hospital Universitario Virgen Macarena
Learn More & Join Trial
EXecutive RCT: Evaluating XIENCE VÂŽ in a Multi Vessel Disease PHASE4 The purpose of this two part study is the assessment of the performance of ...
Show More Location
A.O. San Giovanni di Dio
Learn More & Join Trial
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) PHASE4 This is a prospective, randomized, active-controlled, open label, parallel ...
Show More Learn More & Join Trial